$82.39
0.000.00%
Pre-Market: 4:00 PM EDT
Comments
Loading...
Nuvalent (NUVL) Forecast
NewsEarningsNuvalent (NUVL) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestNuvalent (NASDAQ:NUVL) Stock Quotes, Forecast and News Summary
Nuvalent Stock (NASDAQ: NUVL) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Nuvalent (NUVL) stock?
You can purchase shares of Nuvalent (NASDAQ:NUVL) through any online brokerage.
Who are Nuvalent (NUVL) competitors?
Other companies in Nuvalent’s space includes: Legend Biotech (NASDAQ:LEGN), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA), Exact Sciences (NASDAQ:EXAS) and Ascentage Pharma Group (NASDAQ:AAPG).
What is the forecast, or price target, for Nuvalent (NUVL) stock?
Nuvalent has a consensus price target of $102.62.
What is the current price for Nuvalent (NUVL)?
The stock price for Nuvalent (NASDAQ: NUVL) is $82.39 last updated February 20, 2025 at 4:00 PM EST.
Does Nuvalent (NUVL) pay a dividend?
There are no upcoming dividends for Nuvalent.
When is Nuvalent (NASDAQ:NUVL) reporting earnings?
Nuvalent’s Q1 earnings are confirmed for Thursday, May 8, 2025.
Is Nuvalent (NUVL) going to split?
There is no upcoming split for Nuvalent.
What sector and industry does Nuvalent (NUVL) operate in?
Nuvalent is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.